Class 2 Device Recall BD Multitest" 6color TBNK and BD Multitest" 6color TBNK with optional BD Trucount" Tubes

• Date Initiated by Firm: May 08, 2024
• Date Posted: July 12, 2024
• Recall Status: Open, Classified
• Recall Number: Z-2351-2024
• Recall Event ID: 94830
• 510(K)Number: K170974
• Product Classification: Flow cytometric reagents and accessories. - Product Code OYE
• Product: BD Multitest 6-Color TBNK CE-IVD, REF: 644611; BD Multitest 6-Color TBNK Kit with BD Trucount Tubes CE-IVD, REF: 337166; BD Multitest 6-Color TBNK, IVD, REF: 662967; BD Multitest 6-Color TBNK Kit with BD Trucount Tubes IVD, REF: 662995. BD Multitest" 6-Color TBNK reagent with optional BD Trucount" Tubes is a six-color direct immunofluorescence reagent.
• Code Information: REF/UDI-DI/Lot-Expiration: 644611/382906446114/20010-31-Aug-24, 49510-30-Sep-24, 32674-30-Sep-24; 337166/382903371662/17569-31-Jul-24, 22709-31-Aug-24, 49517-30-Sep-24; 662967/382906629678/17572-31-Jul-24, 17582-31-Jul-24, 26797-31-Aug-24, 69761-30-Sep-24, 49506-30-Sep-24; 662995/382906629951/49508-30-Sep-24
• Recalling Firm/ Manufacturer: Becton, Dickinson and Company, BD Biosciences; 2350 Qume Dr; San Jose CA 95131-1812
• For Additional Information Contact: 408-954-2100
• Manufacturer Reason for Recall: Multitest with compromised raw material used to assess immune system status may result in flow cytometry plot with unusual staining pattern, nonspecific aggregates, high background, double positive event increase on CD3+CD4+vsCD3+CD8+ and/or CD3-CD16+CD56+vsCD3-CD19+, contaminated antibodies, may lead to erroneous or delayed results, additional patient sample, might impact healthcare decisions
• FDA Determined Cause: Material/Component Contamination
• Action: On 5/8/24, correction notices were sent to Lab Managers and Risk Managers asking them to do the following: 1) Discuss the content of this letter with your laboratory management regarding the need to review previous test results associated with these affected lots. 2) Discard all products subject to the recall following your institution s process for destruction. 3) Share and post this customer letter within your facility network and forward to any customers to whom you may have distributed the product to ensure awareness. 4) Complete and return the response form via email to BDRC13@bd.com or fill out the form using this link: https://bdx.my.site.com/CC360/s/impactedproducts?rn=BDB-24-5033 If you require further assistance contact the firm's North American Reginal Complaint Center via phone 1-844-823-5433 Say "Complaints" when prompted Mon Fri 8:00am and 5:00pm CT or via email productcomplaints@bd.com Recall-related questions can be sent via email to BDRC13@bd.com
• Quantity in Commerce: 10,027
• Distribution: US: MN, NJ, NY, MD, UT, FL, NC, MA, KY, NE, NV, CA, LA, DC, OH, MI, PA, WA, CT, AL, DE, TN, IN, OR, IL, WI, NH, TX, GA, RI, SD, ID, NM, AR. OUS: CA, SG, NZ, AU, KR, IN, PE, GT, AR, MX, TW, CN, NI, CR, JP, BR, TH, BE, VN
• Total Product Life Cycle: TPLC Device Report

¹ A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
² Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
³ The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes.

• 510(K) Database: 510(K)s with Product Code = OYE